Selinexor
OSU-14087
Phase 1 small_molecule completed
Quick answer
Selinexor for Prolymphocytic Leukemia is a Phase 1 program (small_molecule) at Karyopharm Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Karyopharm Therapeutics
- Indication
- Prolymphocytic Leukemia
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed